Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Conmed (CNMD) Cash & Current Investments (2016 - 2025)

Historic Cash & Current Investments for Conmed (CNMD) over the last 16 years, with Q4 2025 value amounting to $40.8 million.

  • Conmed's Cash & Current Investments rose 6687.93% to $40.8 million in Q4 2025 from the same period last year, while for Dec 2025 it was $40.8 million, marking a year-over-year increase of 6687.93%. This contributed to the annual value of $40.8 million for FY2025, which is 6687.93% up from last year.
  • According to the latest figures from Q4 2025, Conmed's Cash & Current Investments is $40.8 million, which was up 6687.93% from $38.9 million recorded in Q3 2025.
  • In the past 5 years, Conmed's Cash & Current Investments ranged from a high of $53.2 million in Q2 2022 and a low of $20.8 million during Q4 2021
  • Moreover, its 5-year median value for Cash & Current Investments was $32.4 million (2021), whereas its average is $33.0 million.
  • In the last 5 years, Conmed's Cash & Current Investments plummeted by 4760.69% in 2023 and then skyrocketed by 6687.93% in 2025.
  • Conmed's Cash & Current Investments (Quarter) stood at $20.8 million in 2021, then soared by 38.83% to $28.9 million in 2022, then decreased by 16.05% to $24.3 million in 2023, then rose by 0.67% to $24.5 million in 2024, then skyrocketed by 66.88% to $40.8 million in 2025.
  • Its last three reported values are $40.8 million in Q4 2025, $38.9 million for Q3 2025, and $33.9 million during Q2 2025.